Gain-of-function virology as dual-use research of concern: Variations of securitization in the United States.
Saved in:
| Title: | Gain-of-function virology as dual-use research of concern: Variations of securitization in the United States. |
|---|---|
| Authors: | Kelle, Alexander, Dando, Malcolm |
| Source: | Politics & the Life Sciences. Spring2026, Vol. 45 Issue 1, p141-158. 18p. |
| Subjects: | COVID-19, United States. Congress, Biotechnology, Risk management in business, Medical virology, Biosecurity, Risk assessment |
| Geographic Terms: | United States |
| Abstract: | Ever since the advent of recombinant DNA technology in the early 1970s concerns have been expressed about the misuse potential of this and subsequent biotechnology breakthroughs. This article focuses on the securitization of gain-of-function (GOF) virology research in the United States, utilizing an updated theoretical framework that distinguishes between "riskification" and "threatification." The paper examines three distinct cases, two historical, one ongoing. It argues that early attempts to govern GOF research primarily employed a riskification approach, characterized by self-governance by the scientific community. However, the controversy over the origins of the COVID-19 pandemic led to a shift toward threatification, bringing in high-level political actors like the U.S. President and Congress, resulting in the adoption of more restrictive, legally-enforced oversight measures. The article concludes that the application of this theoretical distinction provides a better understanding of how the governance of dual-use research has evolved in the United States. [ABSTRACT FROM AUTHOR] |
| Copyright of Politics & the Life Sciences is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 192815976 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Gain-of-function virology as dual-use research of concern: Variations of securitization in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kelle%2C+Alexander%22">Kelle, Alexander</searchLink><br /><searchLink fieldCode="AR" term="%22Dando%2C+Malcolm%22">Dando, Malcolm</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Politics+%26+the+Life+Sciences%22">Politics & the Life Sciences</searchLink>. Spring2026, Vol. 45 Issue 1, p141-158. 18p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22United+States%2E+Congress%22">United States. Congress</searchLink><br /><searchLink fieldCode="DE" term="%22Biotechnology%22">Biotechnology</searchLink><br /><searchLink fieldCode="DE" term="%22Risk+management+in+business%22">Risk management in business</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+virology%22">Medical virology</searchLink><br /><searchLink fieldCode="DE" term="%22Biosecurity%22">Biosecurity</searchLink><br /><searchLink fieldCode="DE" term="%22Risk+assessment%22">Risk assessment</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22United+States%22">United States</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Ever since the advent of recombinant DNA technology in the early 1970s concerns have been expressed about the misuse potential of this and subsequent biotechnology breakthroughs. This article focuses on the securitization of gain-of-function (GOF) virology research in the United States, utilizing an updated theoretical framework that distinguishes between "riskification" and "threatification." The paper examines three distinct cases, two historical, one ongoing. It argues that early attempts to govern GOF research primarily employed a riskification approach, characterized by self-governance by the scientific community. However, the controversy over the origins of the COVID-19 pandemic led to a shift toward threatification, bringing in high-level political actors like the U.S. President and Congress, resulting in the adoption of more restrictive, legally-enforced oversight measures. The article concludes that the application of this theoretical distinction provides a better understanding of how the governance of dual-use research has evolved in the United States. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Politics & the Life Sciences is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=192815976 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1017/pls.2025.10018 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 18 StartPage: 141 Subjects: – SubjectFull: COVID-19 Type: general – SubjectFull: United States. Congress Type: general – SubjectFull: Biotechnology Type: general – SubjectFull: Risk management in business Type: general – SubjectFull: Medical virology Type: general – SubjectFull: Biosecurity Type: general – SubjectFull: Risk assessment Type: general – SubjectFull: United States Type: general Titles: – TitleFull: Gain-of-function virology as dual-use research of concern: Variations of securitization in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kelle, Alexander – PersonEntity: Name: NameFull: Dando, Malcolm IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Spring2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 07309384 Numbering: – Type: volume Value: 45 – Type: issue Value: 1 Titles: – TitleFull: Politics & the Life Sciences Type: main |
| ResultId | 1 |